Biomea Fusion, Inc. (BMEA)
NASDAQ: BMEA · Real-Time Price · USD
1.530
+0.210 (15.91%)
At close: Mar 31, 2026, 4:00 PM EDT
1.510
-0.020 (-1.31%)
Pre-market: Apr 1, 2026, 5:26 AM EDT
Biomea Fusion Market Cap
Biomea Fusion has a market cap or net worth of $110.62 million as of April 1, 2026. Its market cap has increased by 21.13% in one year.
Market Cap
110.62M
Enterprise Value
56.40M
1-Year Change
21.13%
Ranking
Category
Stock Price
$1.53
Market Cap Chart
Since the IPO on April 16, 2021, Biomea Fusion's market cap has decreased from $489.05M to $110.62M, a decrease of -77.38%. That is a compound annual growth rate of -25.90%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 31, 2026 | 110.62M | 26.17% |
| Dec 31, 2025 | 87.67M | -37.65% |
| Dec 31, 2024 | 140.61M | -72.88% |
| Dec 29, 2023 | 518.45M | 109.21% |
| Dec 30, 2022 | 247.81M | 14.52% |
| Dec 31, 2021 | 216.38M | -55.75% |
| Apr 16, 2021 | 489.05M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Cardiff Oncology | 105.97M |
| TuHURA Biosciences | 105.05M |
| Genelux | 102.06M |
| Aldeyra Therapeutics | 101.11M |
| Turn Therapeutics | 94.81M |
| Seer, Inc. | 94.50M |
| Coya Therapeutics | 88.67M |
| Oncolytics Biotech | 86.62M |